Global Anti-Senescence Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
SKU ID :GIR-14637351 | Published Date: 31-Oct-2019 | No. of pages: 105Description
TOC
Table of Contents
1 Anti-Senescence Therapy Market Overview
1.1 Product Overview and Scope of Anti-Senescence Therapy
1.2 Classification of Anti-Senescence Therapy by Types
1.2.1 Global Anti-Senescence Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Anti-Senescence Therapy Revenue Market Share by Types in 2018
1.2.3 Gene Therapy
1.2.4 Immunotherapy
1.2.5 Others
1.3 Global Anti-Senescence Therapy Market by Application
1.3.1 Global Anti-Senescence Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cardiovascular Diseases
1.3.3 Neural Degenerative Diseases
1.3.4 Ophthalmology Disorders
1.3.5 Others
1.4 Global Anti-Senescence Therapy Market by Regions
1.4.1 Global Anti-Senescence Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-Senescence Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Anti-Senescence Therapy (2014-2024)
2 Company Profiles
2.1 Unity Biotechnology
2.1.1 Business Overview
2.1.2 Anti-Senescence Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Unity Biotechnology Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 OisinBiotechnologies
2.2.1 Business Overview
2.2.2 Anti-Senescence Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 OisinBiotechnologies Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 AgeX Therapeutics，Inc
2.3.1 Business Overview
2.3.2 Anti-Senescence Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AgeX Therapeutics，Inc Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Siwa Therapeutics
2.4.1 Business Overview
2.4.2 Anti-Senescence Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Siwa Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Cleara Biotech
2.5.1 Business Overview
2.5.2 Anti-Senescence Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cleara Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Calico LLC
2.6.1 Business Overview
2.6.2 Anti-Senescence Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Calico LLC Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sierra Sciences
2.7.1 Business Overview
2.7.2 Anti-Senescence Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sierra Sciences Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Human Longevity, Inc. (HLI)
2.8.1 Business Overview
2.8.2 Anti-Senescence Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Human Longevity, Inc. (HLI) Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Numeric Biotech
2.9.1 Business Overview
2.9.2 Anti-Senescence Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Numeric Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 Recursion Pharmaceuticals
2.10.1 Business Overview
2.10.2 Anti-Senescence Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Recursion Pharmaceuticals Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 Proteostasis Therapeutics
2.11.1 Business Overview
2.11.2 Anti-Senescence Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Proteostasis Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.12 Senolytic Therapeutics
2.12.1 Business Overview
2.12.2 Anti-Senescence Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Senolytic Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.13 Allergan
2.13.1 Business Overview
2.13.2 Anti-Senescence Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Allergan Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anti-Senescence Therapy Market Competition, by Players
3.1 Global Anti-Senescence Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Anti-Senescence Therapy Players Market Share
3.2.2 Top 10 Anti-Senescence Therapy Players Market Share
3.3 Market Competition Trend
4 Global Anti-Senescence Therapy Market Size by Regions
4.1 Global Anti-Senescence Therapy Revenue and Market Share by Regions
4.2 North America Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
5 North America Anti-Senescence Therapy Revenue by Countries
5.1 North America Anti-Senescence Therapy Revenue by Countries (2014-2019)
5.2 USA Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6 Europe Anti-Senescence Therapy Revenue by Countries
6.1 Europe Anti-Senescence Therapy Revenue by Countries (2014-2019)
6.2 Germany Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6.4 France Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Anti-Senescence Therapy Revenue by Countries
7.1 Asia-Pacific Anti-Senescence Therapy Revenue by Countries (2014-2019)
7.2 China Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7.5 India Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
8 South America Anti-Senescence Therapy Revenue by Countries
8.1 South America Anti-Senescence Therapy Revenue by Countries (2014-2019)
8.2 Brazil Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Anti-Senescence Therapy by Countries
9.1 Middle East and Africa Anti-Senescence Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
10 Global Anti-Senescence Therapy Market Segment by Type
10.1 Global Anti-Senescence Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Anti-Senescence Therapy Market Forecast by Type (2019-2024)
10.3 Gene Therapy Revenue Growth Rate (2014-2024)
10.4 Immunotherapy Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Anti-Senescence Therapy Market Segment by Application
11.1 Global Anti-Senescence Therapy Revenue Market Share by Application (2014-2019)
11.2 Anti-Senescence Therapy Market Forecast by Application (2019-2024)
11.3 Cardiovascular Diseases Revenue Growth (2014-2019)
11.4 Neural Degenerative Diseases Revenue Growth (2014-2019)
11.5 Ophthalmology Disorders Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Anti-Senescence Therapy Market Size Forecast (2019-2024)
12.1 Global Anti-Senescence Therapy Market Size Forecast (2019-2024)
12.2 Global Anti-Senescence Therapy Market Forecast by Regions (2019-2024)
12.3 North America Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
12.6 South America Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Tables & Figures
List of Tables and Figures
Figure Anti-Senescence Therapy Picture
Table Product Specifications of Anti-Senescence Therapy
Table Global Anti-Senescence Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Anti-Senescence Therapy Revenue Market Share by Types in 2018
Figure Gene Therapy Picture
Figure Immunotherapy Picture
Figure Others Picture
Table Global Anti-Senescence Therapy Revenue (Million USD) by Application (2014-2024)
Figure Anti-Senescence Therapy Revenue Market Share by Applications in 2018
Figure Cardiovascular Diseases Picture
Figure Neural Degenerative Diseases Picture
Figure Ophthalmology Disorders Picture
Figure Others Picture
Table Global Market Anti-Senescence Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Unity Biotechnology Basic Information, Manufacturing Base and Competitors
Table Unity Biotechnology Anti-Senescence Therapy Type and Applications
Table Unity Biotechnology Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table OisinBiotechnologies Basic Information, Manufacturing Base and Competitors
Table OisinBiotechnologies Anti-Senescence Therapy Type and Applications
Table OisinBiotechnologies Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table AgeX Therapeutics，Inc Basic Information, Manufacturing Base and Competitors
Table AgeX Therapeutics，Inc Anti-Senescence Therapy Type and Applications
Table AgeX Therapeutics，Inc Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Siwa Therapeutics Basic Information, Manufacturing Base and Competitors
Table Siwa Therapeutics Anti-Senescence Therapy Type and Applications
Table Siwa Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cleara Biotech Basic Information, Manufacturing Base and Competitors
Table Cleara Biotech Anti-Senescence Therapy Type and Applications
Table Cleara Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Calico LLC Basic Information, Manufacturing Base and Competitors
Table Calico LLC Anti-Senescence Therapy Type and Applications
Table Calico LLC Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Sierra Sciences Basic Information, Manufacturing Base and Competitors
Table Sierra Sciences Anti-Senescence Therapy Type and Applications
Table Sierra Sciences Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Human Longevity, Inc. (HLI) Basic Information, Manufacturing Base and Competitors
Table Human Longevity, Inc. (HLI) Anti-Senescence Therapy Type and Applications
Table Human Longevity, Inc. (HLI) Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Numeric Biotech Basic Information, Manufacturing Base and Competitors
Table Numeric Biotech Anti-Senescence Therapy Type and Applications
Table Numeric Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Recursion Pharmaceuticals Anti-Senescence Therapy Type and Applications
Table Recursion Pharmaceuticals Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Proteostasis Therapeutics Basic Information, Manufacturing Base and Competitors
Table Proteostasis Therapeutics Anti-Senescence Therapy Type and Applications
Table Proteostasis Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Senolytic Therapeutics Basic Information, Manufacturing Base and Competitors
Table Senolytic Therapeutics Anti-Senescence Therapy Type and Applications
Table Senolytic Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Anti-Senescence Therapy Type and Applications
Table Allergan Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Anti-Senescence Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Anti-Senescence Therapy Revenue Share by Players (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Players in 2017
Figure Global Anti-Senescence Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Anti-Senescence Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Anti-Senescence Therapy Revenue Market Share in 2018
Figure Global Anti-Senescence Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Anti-Senescence Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Anti-Senescence Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Market Share by Regions in 2018
Figure North America Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure South America Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table North America Anti-Senescence Therapy Revenue by Countries (2014-2019)
Table North America Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure USA Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table Europe Anti-Senescence Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure Germany Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure UK Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure France Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Anti-Senescence Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure China Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure India Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table South America Anti-Senescence Therapy Revenue by Countries (2014-2019)
Table South America Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure Brazil Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Anti-Senescence Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anti-Senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anti-Senescence Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Anti-Senescence Therapy Revenue and Growth Rate (2014-2019)
Table Global Anti-Senescence Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Anti-Senescence Therapy Revenue Share by Type (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Type (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Type in 2018
Table Global Anti-Senescence Therapy Revenue Forecast by Type (2019-2024)
Figure Global Anti-Senescence Therapy Market Share Forecast by Type (2019-2024)
Figure Global Gene Therapy Revenue Growth Rate (2014-2019)
Figure Global Immunotherapy Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Anti-Senescence Therapy Revenue by Application (2014-2019)
Table Global Anti-Senescence Therapy Revenue Share by Application (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Application (2014-2019)
Figure Global Anti-Senescence Therapy Revenue Share by Application in 2018
Table Global Anti-Senescence Therapy Revenue Forecast by Application (2019-2024)
Figure Global Anti-Senescence Therapy Market Share Forecast by Application (2019-2024)
Figure Global Cardiovascular Diseases Revenue Growth Rate (2014-2019)
Figure Global Neural Degenerative Diseases Revenue Growth Rate (2014-2019)
Figure Global Ophthalmology Disorders Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Anti-Senescence Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Anti-Senescence Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Anti-Senescence Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
Figure Europe Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
Figure South America Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Anti-Senescence Therapy Revenue Market Forecast (2019-2024)
Companies
Unity Biotechnology
OisinBiotechnologies
AgeX Therapeutics，Inc
Siwa Therapeutics
Cleara Biotech
Calico LLC
Sierra Sciences
Human Longevity, Inc. (HLI)
Numeric Biotech
Recursion Pharmaceuticals
Proteostasis Therapeutics
Senolytic Therapeutics
Allergan
- PRICE
-
$3480$6960